Reverse ventricular remodelling after cardiac resynchronization therapy is associated with a reduction in serum tenascin-C and plasma matrix metalloproteinase-9 levels (Q80865656)
Jump to navigation
Jump to search
scientific article published on 28 August 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Reverse ventricular remodelling after cardiac resynchronization therapy is associated with a reduction in serum tenascin-C and plasma matrix metalloproteinase-9 levels |
scientific article published on 28 August 2007 |
Statements
Reverse ventricular remodelling after cardiac resynchronization therapy is associated with a reduction in serum tenascin-C and plasma matrix metalloproteinase-9 levels (English)
Marleen H M Hessel
Gabe B Bleeker
Jeroen J Bax
Maureen M Henneman
Brigit den Adel
Margreet Klok
M J Schalij
Douwe E Atsma
Arnoud van der Laarse
28 August 2007